ArticleDepression research and treatment2023
Prevalence of Depression and Its Associated Factors among Prisoners in North Wollo Zone, Northeastern Ethiopia: A Cross-Sectional Study.
Article in Depression research and treatment, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 6 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Depression is a psychiatric disorder that is characterized by persistent sadness and a lack of interest or pleasure in previously rewarding and enjoyable activities. It is one of the leading mental disorders among prisoners worldwide. However, little attention is given to this condition, especially in developing countries. Hence, this study was aimed at assessing the prevalence of depression and its associated factors among prisoners in North Wollo Zone Correctional Institutions, Ethiopia. Methods: A cross-sectional study was carried out among 407 prisoners from November 20 to December 20, 2020. A simple random sampling technique was employed to select the study participants, and the Patient Health Questionnaire-9 (PHQ-9) was utilized to measure the prevalence of depression among prisoners. Data analyses were done using SPSS version 20 software program. Descriptive and inferential statistics including bivariate and multivariable regression analyses were run to assess the association between depression and the independent variables, and a Results: A total of 407 prisoners participated in the study, making the response rate 96.9%. The mean age of the participants was 31.7 ± 12.83. Forty-one percent of them were between the ages of 18 and 27 years. In this study, the prevalence of depression was 55.5%. Age 38-47 (AOR = 4.29; 95%CI = 1.51, 12.20), having children (AOR = 2.75; 95%CI = 1.40, 5.42), sentences for 5-10 years and over 10 years (AOR = 6.26; 95%CI = 3.19, 12.30 and AOR = 7.71; 95%CI = 3.47, 17.17, respectively), having a history of mental illness (AOR = 5.22; 95%CI = 2.39, 11.36), having two or more stressful life events (AOR = 6.61; 95%CI = 2.73, 15.96), and poor social support (AOR = 8.13; 95%CI = 3.43, 19.27) were significantly associated with depression. Conclusions: In this study, more than half of the study participants were found having depression which is relatively higher compared with other previous studies across the globe. Moreover, different variables including the inmate's age of 38-47 years, having children, a sentence of 5-10 and over 10 years, history of mental illness, having two or more stressful life events, and poor social support were factors significantly associated with depression. Thus, awareness creation for police officers and prison managers about depression screening in prison and treatment programs including psychological counseling and cognitive behavioral therapy for prisoners are recommended.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.